-
Mashup Score: 1039
Study on hydroxychloroquine by Didier Raoult and colleagues gets pulled on ethical and scientific grounds
Source: www.science.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 7
Novavax is just as effective, but far less likely to cause fevers and fatigue.
Source: www.vox.comCategories: General Medicine News, Infectious DiseaseTweet-
In this piece I’m quoted about the Novavax #covid19 vaccine which is under appreciated and may be advantageous given lower side effect profile and possibly less waning of antibody levels https://t.co/oNjr0yqRE0
-
-
Mashup Score: 1010
Study on hydroxychloroquine by Didier Raoult and colleagues gets pulled on ethical and scientific grounds
Source: www.science.orgCategories: General Medicine News, Future of MedicineTweet-
Breaking news: A 2020 paper that sparked widespread enthusiasm for hydroxychloroquine as a #COVID19 treatment has been retracted, following campaigning that alleged the research contained major scientific flaws and may have breached ethics regulations. https://t.co/v6EhKM8JP8
-
-
Mashup Score: 0Decline of antibodies to major viral and bacterial respiratory pathogens during the COVID-19 pandemic - 7 day(s) ago
Antibodies to respiratory syncytial virus and Group A Streptococcus waned significantly in a longitudinal cohort throughout the pandemic. This waning may h
Source: academic.oup.comCategories: General Medicine News, Infectious DiseaseTweet-
Following the relaxing of #COVID19 restrictions, we have seen surges in flu, RSV, and Group A Strep infections. There was a waning of immunity to these infections as fewer people were exposed due to masking and social distancing. https://t.co/moL1ahb8V7
-
-
Mashup Score: 41COVID-19 policy briefs - 9 day(s) ago
To assist national and global efforts to end the COVID-19 emergency worldwide, WHO updated the COVID-19 Global Preparedness, Readiness and Response plan in 2022 and outlined two strategic objectives. To provide actionable approaches to meeting these objectives, WHO has produced six short policy briefs that are based on previously published technical guidance.
Source: www.who.intCategories: General Medicine News, General HCPsTweet-
#COVID19 has not gone away, but now we know much better how to manage it. @WHO has released a package of updated policy briefs to help countries reduce illness, deaths and the long-term consequences of the disease: https://t.co/fBdu9BtBFv https://t.co/PBqZbcth2R
-
-
Mashup Score: 377COVID-19 policy briefs - 10 day(s) ago
To assist national and global efforts to end the COVID-19 emergency worldwide, WHO updated the COVID-19 Global Preparedness, Readiness and Response plan in 2022 and outlined two strategic objectives. To provide actionable approaches to meeting these objectives, WHO has produced six short policy briefs that are based on previously published technical guidance.
Source: www.who.intCategories: General Medicine News, General HCPsTweet-
#COVID19 has not gone away, but now we know much better how to manage it. @WHO has released a package of updated policy briefs to help countries reduce illness, deaths and the long-term consequences of the disease: https://t.co/fBdu9BtBFv https://t.co/PBqZbcth2R
-
-
Mashup Score: 0Optimal Timing Determined for COVID-19 Vaccination Booster - 10 day(s) ago
Study finds optimal timing of annual COVID-19 booster depends on regional transmission patterns and if/when breakthrough infection has occurred.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
A new study led by Dr. Jeffrey Townsend from the @YaleSPH finds optimal timing of annual #COVID19 booster depends on regional transmission patterns and if/when breakthrough infection has occurred. https://t.co/HyznyjPGfF
-
-
Mashup Score: 1
This case-control study of US children examines vaccine effectiveness rates of a messenger RNA vaccine during the 2023-2024 respiratory virus season.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
The BNT162b2 XBB vaccine provided protection against #COVID19 hospitalization and ER and urgent care visits among children 5-17y during the 2023-24 season, with estimated vaccine efficacy of 63–73%. https://t.co/UDB4mqthfT https://t.co/N1B4ASlWcl
-
-
Mashup Score: 0
Timely remdesivir treatment in immunocompromised patients infected with COVID-19 is associated with improved survival outcomes.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
A 25% lower all-cause mortality is associated with timely initiation of remdesivir in immunocompromised patients hospitalized for #COVID19. https://t.co/inLteP4Iy9
-
-
Mashup Score: 13Quick takes: WHO XEC risk assessment, record dengue in the Americas, wastewater polio detection in Finland - 13 day(s) ago
The WHO said the increasing XEC COVID-19 variant isn’t likely to burden healthcare systems as much as earlier variants.
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet-
Quick takes: WHO XEC risk assessment, record dengue in the Americas, wastewater polio detection in Finland The WHO said the increasing XEC #COVID19 variant isn't likely to burden healthcare systems as much as earlier variants https://t.co/dJeokIEP2z
-
Breaking news: A 2020 paper that sparked widespread enthusiasm for hydroxychloroquine as a #COVID19 treatment has been retracted, following campaigning that alleged the research contained major scientific flaws and may have breached ethics regulations. https://t.co/v6EhKM8JP8